Winslow Capital Management LLC increased its holdings in Stryker Co. (NYSE:SYK) by 215,255.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,109,079 shares of the medical technology company’s stock after purchasing an additional 1,108,564 shares during the period. Winslow Capital Management LLC owned 0.30% of Stryker worth $197,061,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. DekaBank Deutsche Girozentrale grew its position in Stryker by 12.4% during the third quarter. DekaBank Deutsche Girozentrale now owns 226,427 shares of the medical technology company’s stock valued at $38,488,000 after acquiring an additional 25,015 shares during the period. FMR LLC lifted its stake in shares of Stryker by 4.8% in the third quarter. FMR LLC now owns 5,581,594 shares of the medical technology company’s stock worth $991,737,000 after acquiring an additional 253,732 shares in the last quarter. Blue Fin Capital Inc. lifted its stake in shares of Stryker by 13.8% in the third quarter. Blue Fin Capital Inc. now owns 7,047 shares of the medical technology company’s stock worth $1,252,000 after acquiring an additional 857 shares in the last quarter. FIL Ltd lifted its stake in shares of Stryker by 3.4% in the third quarter. FIL Ltd now owns 184,222 shares of the medical technology company’s stock worth $32,733,000 after acquiring an additional 6,001 shares in the last quarter. Finally, Rosenblum Silverman Sutton S F Inc. CA acquired a new position in shares of Stryker in the third quarter worth about $3,903,000. 74.87% of the stock is owned by institutional investors and hedge funds.
Several research analysts recently commented on SYK shares. Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $186.00 price target on the stock in a research note on Tuesday, August 7th. BTIG Research started coverage on Stryker in a research note on Thursday, August 16th. They issued a “buy” rating and a $187.00 price target on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Stryker in a research note on Tuesday, September 11th. JPMorgan Chase & Co. boosted their price target on Stryker to $200.00 and gave the stock an “overweight” rating in a research note on Thursday, September 13th. Finally, Barclays started coverage on Stryker in a research note on Monday, October 15th. They issued an “overweight” rating and a $198.00 price target on the stock. Eight analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $181.86.
NYSE SYK traded up $0.45 on Friday, hitting $164.79. 3,592 shares of the stock traded hands, compared to its average volume of 1,434,256. Stryker Co. has a twelve month low of $146.80 and a twelve month high of $179.84. The stock has a market capitalization of $61.49 billion, a P/E ratio of 25.42, a PEG ratio of 2.26 and a beta of 0.64. The company has a quick ratio of 1.21, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.
Stryker (NYSE:SYK) last posted its earnings results on Thursday, October 25th. The medical technology company reported $1.69 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.68 by $0.01. The company had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.26 billion. Stryker had a return on equity of 28.00% and a net margin of 9.31%. On average, analysts anticipate that Stryker Co. will post 7.28 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, October 31st. Stockholders of record on Friday, September 28th were issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 1.14%. The ex-dividend date of this dividend was Thursday, September 27th. Stryker’s dividend payout ratio (DPR) is presently 28.97%.
ILLEGAL ACTIVITY WARNING: “Stryker Co. (SYK) Stake Raised by Winslow Capital Management LLC” was originally published by WKRB News and is the sole property of of WKRB News. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.wkrb13.com/2018/11/23/stryker-co-syk-stake-raised-by-winslow-capital-management-llc.html.
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Featured Article: Conference Calls
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.